Opioid-induced muscle activity: implications for managing chronic pain

Area of Science:

• Pharmacology
• Neurology
• Oncology

Background:

• Opioid analgesics are commonly used for cancer pain management.
• Chronic opioid therapy can lead to adverse effects, including neuromuscular complications.
• Opioid-induced involuntary muscle hyperactivity is a recognized, though less common, adverse effect.

Observation:

• A ventilator-dependent patient with metastatic lung cancer experienced increasing unresponsiveness.
• The patient exhibited involuntary muscle hyperactivity despite escalating morphine infusion rates.
• This hyperactivity was initially misinterpreted as breakthrough pain.

Findings:

• Involuntary muscle hyperactivity can be a sign of opioid toxicity, not necessarily undertreated pain.
• High-dose opioid infusions, particularly morphine, may precipitate this condition.
• The case highlights the challenge of assessing pain in unresponsive patients.

Implications:

• Increased awareness of opioid-induced muscle hyperactivity is crucial for clinicians.
• Management strategies should include considering opioid toxicity in unresponsive patients.
• Reducing opioid dosage and/or administering clonazepam are recommended interventions.